Tiantan Biological changes legal representative, waives acquisition opportunity

Beijing Tiantan Biological Products Corp. shareholders approved changing the company's legal representative, with 99.45% of A shares voting in favor.

Shareholders also approved waiving the opportunity to acquire Palin Bio Commercial Opportunity, with 94.99% of A shares supporting the decision. The proposal involved connected transactions, with associated shareholders including China National Biotec Group abstaining from voting.